FDA Investigator Dov Pluznik, PhD
Dov Pluznik, PhD has inspections in 2 countries as of 05 Jul 2023. Dov Pluznik, PhD has collaborated with a combined 1213 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
05 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Germany
Co-Investigator(s):
Adaliz Santaliz Cruz,
Alan A Rivera,
Andrea George, PhD,
Arlene M Badillo,
Ashley N Queen, PhD,
Calvin B Koerner,
Christopher Downey, PhD,
Colleen Thomas, PhD,
Dennis Cantellops Paite,
Donald C Obenhuber, PhD,
Eliezar Ramos,
Erika V Butler,
Ivis Lnegron Torres,
Jacqueline Mdiaz Albertini,
James I Giefer,
Jennifer Lalama,
Jerri Baker,
Jorge L Lajara,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose E Melendez, DDC,
Jose R Lopez,
Jose Velez,
Kevin D Kallander,
Libia M Lugo,
LT Rafael Gonzalez,
Maria Gutierrez Lugo, PhD,
Marian E Ramirez,
Maxwell Van Tassell, PhD,
Michael A Charles,
Michael Shanks, MS,
Michele Perry Williams,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Milva E Melendez,
Milva Emelendez Perales,
Myriam M Sosa,
Nicholas Obiri, PhD,
Nikolay Spiridonov,
Noreen Muniz,
Noreen Muñiz,
Nydia E Colon,
Omotunde O Osunsanmi,
Patricia Fhughes Troost,
Paul Z Balcer,
Paula A Trost,
Ramesh Potla, PhD,
Ramon A Hernandez,
Rebecca E Dombrowski,
Rebecca Parrilla,
Rebecca Rodriguez,
Riley C Myers, PhD,
Robert Darius,
Steven C Madzo,
Steven Fong, MS, PhD,
Susan M Jackson,
Thomas J Arista,
Timothy Wadkin, PhD,
Vilmary Negron Rodriguez,
Wendy G Tan, PhD,
Zachary L Stamm,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD
Dov Pluznik, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2005 | FDA 483 | Amgen Manufacturing Ltd - Form 483, 2005-05-20 |
September, 2001 | EIR | Aventis Behring Gmbh - EIR, 2001-11-15 |
May, 2005 | EIR | Amgen Manufacturing Ltd - EIR, 2005-05-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more